The National Health Institute (INS) is accelerating the completion of a
at the first level of care, its head Cesar Cabezas affirmed on Friday.
In addition, Cabezas said that an exclusive laboratory for the molecular diagnosis of COVID-19 —with a maximum capacity for 6,000 samples per day— was enabled in automated and semi-automated equipment.
Additionally, the health official highlighted that important evidence related to the
diagnosis, treatment, prevention and control of COVID-19 was generated in the country, which became a technical contribution for the approval and updating of public health standards for the control of said virus.
As a result of its research, the INS carried out the sequencing and analysis of the SARS-CoV-2 genomes from patients in Peru.
This study is of great importance as it will allow the INS to identify virus mutations and expansion routes nationwide, providing important information for the design and evaluation of vaccines and treatments
against COVID-19.